Delivery Order SPE2DB20D2014-SPE2DB25FB74V

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,530.64 contract is for the supply of Mounjaro 5 mg/0.5 ml pens, a diabetes medication. The order has an ultimate completion date of April 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,465.65 firm fixed-price contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of February 26, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mounjaro 7.5 mg/0.5 ml pens, a diabetes medication. The contract has a ceiling value of $3,974.26 and a completion date of May 8, 2025. This award is not set aside and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,842.89, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a period of performance through May 6, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,448.81, is for the provision of Mounjaro 7.5 mg/0.5 ml pens, a diabetes treatment medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is part...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,902.62, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,874.91 firm-fixed-price contract is for the supply of Mounjaro 5 mg/0.5 ml pens, a diabetes medication. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,758.60, is for the supply of the diabetes medication Mounjaro 7.5 mg/0.5 ml pen. The delivery order has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mounjaro 2.5 mg/0.5 ml pens, a diabetes medication. The contract has a firm fixed price of $10,035.64 and a period of performance ending on May 14, 2025. The contract is not set aside and was awarded on May 13, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,742.80 contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a diabetes medication. The delivery order has an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB74V
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,897.62, is for the supply of Mounjaro 7.5 mg/0.5 ml pens, a diabetes medication. The contract has an ultimate completion date of April 28, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide through December 2026.

Generated 7/25/25, 11:34 AM